Skip to main content
Premium Trial:

Request an Annual Quote

MolecularMD Receives CLIA Certification for Second Lab

NEW YORK (GenomeWeb News) – Molecular diagnostics company MolecularMD has received CLIA certification for its next-generation sequencing laboratory in Cambridge, Mass.

The laboratory was originally established as a development center for next-gen sequencing and has been expanded to provide next-gen sequencing-based clinical testing to support clinical trials.

The firm's Portland, Ore.-based laboratory received CLIA certification in 2006.

"We are working productively with several top pharmaceutical clients to meet their biomarker evaluation and companion diagnostic requirements, supporting early stage proof-of-concept as well as drug/diagnostic co-development programs for FDA approval," Chief Technology Officer Glenn Miller said in a statement.

MolecularMD has developed a number of NGS-based cancer panels that target genomic regions containing genes that are the target of drugs or related to drug response or resistance. For instance, it recently published on custom NGS cancer panels for gastrointestinal stromal tumors, the detection of a specific EGFR mutation in plasma, LKB1/STK11 mutations, and drug resistance conferring mutations to BCR-ABL1.

The company has proprietary chemistry and data analysis pipelines that enable it to detect insertions and deletions up to 50 base pairs and to phase the mutations.

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.